IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL

Table 2

Correlations between the expression level of IGFBP3 and clinicopathological factors in ABC-DLBCL patients from the GEO database.

Variables		Expression level of IGFBP3		value
		Low	High
Age				0.159
	≤60	20	28
	>60	53	45
Sex				0.238
	Female	33	26
	Male	40	47
Stage				0.020
	I-II	25	39
	III-IV	48	34
Extranodal infiltration				0.033
	≤1	50	61
	>1	23	12
ECOG score				0.442
	≤1	53	57
	>1	20	16
LDH				0.011
	Normal	22	37
	Elevated	51	36
IPI score				0.007
	≤2	36	52
	>2	37	21
Treatment response				0.706
	CR	53	55
	Non-CR	20	18

ECOG, eastern cooperative oncology group performance status; LDH, lactate dehydrogenase; IPI, international prognostic index; CR, complete response; non-CR, partial response, stable disease, progressive disease; bold, significant difference.